会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明专利
    • Apparatus and method for maintaining and/or restoring viability of organ
    • 维护和/或恢复机构可行性的装置和方法
    • JP2012092111A
    • 2012-05-17
    • JP2011256847
    • 2011-11-24
    • Organ Recovery Systems Incオーガン リカヴァリー システムズ インコーポレイテッド
    • OWEN DONALD RKRAVITZ DAVID CBRASSIL JOHNBROCKBANK KELVIN G MBURROUGHS ANDREWISAACS DICKONSTEIBEL DENNIS JFRASER RICHARDHARRIS STANLEYSCHEIN DOUGLAS
    • A01N1/02C12M3/00
    • A01N1/0273A01N1/02A01N1/0247
    • PROBLEM TO BE SOLVED: To provide an organ perfusion apparatus and method for storing organs for storage and/or transport of the organs.SOLUTION: The method includes perfusing the organ at hypothermic and/or normothermic temperatures, after hypothermic organ flushing. Organ viability is restored by restoring high energy nucleotide (e.g., ATP) levels by perfusing the organ with a medical fluid at normothermic temperatures. In perfusion, organ perfusion pressure is preferably controlled in response to a sensor disposed in an end of tubing placed in the organ, by a pressurized medical fluid reservoir 10, to prevent overpressurization and to enable emergency flow cut-off. The medical fluid may be fed into the organ from an intermediary tank having a low pressure head to avoid organ overpressurization. As a result, damage to vascular endothelial lining and to organ tissue in general are prevented or reduced. Viability of the organ may be automatically monitored by monitoring characteristics of the medical fluid perfusate. The perfusion process can be automatically controlled by using a control program.
    • 要解决的问题:提供一种器官灌注装置和方法,用于存储器官的储存和/或运输器官。 解决方案:该方法包括在低温器官冲洗后在低温和/或正常体温下灌注器官。 通过用正常体温温度下的医用流体灌注器官来恢复高能量核苷酸(例如ATP)水平来恢复器官活力。 在灌注中,器官灌注压力优选地响应于设置在置于器官中的管的末端中的传感器,通过加压医疗液体储存器10来控制,以防止过压并且使得能够进行紧急流动切断。 可以从具有低压头的中间容器将药液输送到器官中,以避免器官过压。 结果,防止或减少对血管内皮衬里和器官组织的损伤。 可以通过监测医用液体灌注液的特性来自动监测器官的活力。 灌注过程可以通过使用控制程序自动控制。 版权所有(C)2012,JPO&INPIT
    • 2. 发明专利
    • Apparatus and method for maintaining and/or restoring viability of organ
    • 维护和/或恢复机构可行性的装置和方法
    • JP2012092113A
    • 2012-05-17
    • JP2011256852
    • 2011-11-24
    • Organ Recovery Systems Incオーガン リカヴァリー システムズ インコーポレイテッド
    • OWEN DONALD RKRAVITZ DAVID CBRASSIL JOHNBROCKBANK KELVIN G MBURROUGHS ANDREWISAACS DICKONSTEIBEL DENNIS JFRASER RICHARDHARRIS STANLEYSCHEIN DOUGLAS
    • A01N1/02C12M3/00
    • A01N1/0273A01N1/02A01N1/0247
    • PROBLEM TO BE SOLVED: To provide an organ perfusion apparatus and a method for monitoring, sustaining and/or restoring viability of organs and storing the organs for storage and/or transport.SOLUTION: The method includes perfusing the organ at hypothermic and/or normothermic temperatures, after hypothermic organ flushing for organ transport and/or storage. The method can be practiced with prior or subsequent static or perfusion hypothermic exposure of the organ. Organ viability is restored by restoring high energy nucleotide (e.g., ATP) levels by perfusing the organ with a medical fluid at normothermic temperatures. In perfusion, organ perfusion pressure is preferably controlled in response to a sensor disposed in an end of tubing placed in the organ, by a pressurized medical fluid reservoir 10. The medical fluid may be fed into the organ from an intermediary tank having a low pressure head to prevent or reduce damage to vascular endothelial lining and to organ tissue in general. The viability of the organ may be automatically monitored, preferably by monitoring characteristics of the medical fluid perfusate.
    • 要解决的问题:提供器官灌注装置和用于监测,维持和/或恢复器官的活力并存储用于储存和/或运输的器官的方法。 解决方案:该方法包括在器官运输和/或储存的低温器官冲洗后,以低体温和/或正常体温温度灌注器官。 该方法可以在先前或随后的器官的静态或灌注低温暴露下进行。 通过用正常体温温度下的医用流体灌注器官来恢复高能量核苷酸(例如ATP)水平来恢复器官活力。 在灌注中,器官灌注压优选地通过设置在置于器官中的管的端部中的传感器由加压的医用流体储存器10来控制。医用流体可以从具有低压的中间容器 防止或减少对血管内皮衬里和器官组织的损伤。 优选通过监测医用液体灌注液的特性来自动监测器官的活力。 版权所有(C)2012,JPO&INPIT
    • 3. 发明专利
    • Apparatus and method for maintaining and/or restoring viability of organ
    • 维护和/或恢复机构可行性的装置和方法
    • JP2012092114A
    • 2012-05-17
    • JP2011256854
    • 2011-11-24
    • Organ Recovery Systems Incオーガン リカヴァリー システムズ インコーポレイテッド
    • OWEN DONALD RKRAVITZ DAVID CBRASSIL JOHNBROCKBANK KELVIN G MBURROUGHS ANDREWISAACS DICKONSTEIBEL DENNIS JFRASER RICHARDHARRIS STANLEYSCHEIN DOUGLAS
    • A01N1/02C12M3/00
    • A01N1/0273A01N1/02A01N1/0247
    • PROBLEM TO BE SOLVED: To provide an organ perfusion apparatus and a method for monitoring, sustaining and/or restoring viability of organs and storing the organs for storage and/or transport.SOLUTION: The method includes perfusing the organ at hypothermic and/or normothermic temperatures, after hypothermic organ flushing for organ transport and/or storage. The method can be practiced with prior or subsequent static or perfusion hypothermic exposure of the organ. Organ viability is restored by restoring high energy nucleotide (e.g., ATP) levels by perfusing the organ with a medical fluid at normothermic temperatures. In perfusion, organ perfusion pressure is preferably controlled in response to a sensor disposed in an end of tubing placed in the organ, by a pressurized medical fluid reservoir 10. The damage to vascular endothelial lining and to organ tissue in general is prevented or reduced by evading the overpressurization of the organs. The viability of the organ may be automatically monitored, preferably by monitoring characteristics of the medical fluid perfusate.
    • 要解决的问题:提供器官灌注装置和用于监测,维持和/或恢复器官的活力并存储用于储存和/或运输的器官的方法。 解决方案:该方法包括在器官运输和/或储存的低温器官冲洗后,以低体温和/或正常体温温度灌注器官。 该方法可以在先前或随后的器官的静态或灌注低温暴露下进行。 通过用正常体温温度下的医用流体灌注器官来恢复高能量核苷酸(例如ATP)水平来恢复器官活力。 在灌注中,器官灌注压力优选地通过设置在置于器官中的管的端部中的传感器由加压的医用液体储存器10进行控制。一般来说,防止或减少对血管内皮衬里和器官组织的损伤 逃避器官超压。 优选通过监测医用液体灌注液的特性来自动监测器官的活力。 版权所有(C)2012,JPO&INPIT
    • 5. 发明申请
    • APPARATUS AND METHOD FOR MAINTAINING AND/OR RESTORING VIABILITY OF ORGANS
    • 维护和/或恢复机构可行性的装置和方法
    • WO0226034A3
    • 2003-03-20
    • PCT/US0126591
    • 2001-08-27
    • ORGAN RECOVERY SYSTEMS INC
    • OWEN DONALD RKRAVITZ DAVID CBRASSIL JOHNBROCKBANK KELVIN G MBURROUGHS ANDREWISAACS DICKONSTEIBEL DENNIS JFRASER RICHARDHARRIS STANLEYSCHEIN DOUGLAS
    • A01N1/02C12M3/00
    • A01N1/0273A01N1/02A01N1/0247
    • An organ perfusion apparatus and method monitor, sustain and/or restore vability of organs and preserver organs for storage and/or transport. Other apparatus include an organ transporter, an organ cassette and an organ diagnostic device. The method includes perfusing the organ at hypothermic and/or normothermic temperatures, preferably after hypothermic organ flushing for organ transport and/or storage. The method can be practiced with prior or subsequent static or perfusion hypothermic exposure of the organ. Organ viability is restored by restoring high energy nucleotide (e.g., ATP) levels by perfusing the organ with a medical fluid, such as an oxygeneted cross-linked hemoglobin-based bicarbonate medical fluid, at normothermic temperatures. In perfusion, organ perfusion pressure is preferably controlled in response to a sensor disposed in an end of tubuing placed in the organ, by a pneumatically pressurized medical fluid reservoir, providing perfusion pressure fine tuning, overpressurization preventing and emergency flow cut-off. In the hypothermic mode, the organ is perfused with a medical fluid, preferably a simple crystalloid solution containing antioxidants, intermittently or in slow continuous flow. The medical fluid may be fed into the organ from an intermediary tank having a low pressure head to avoid organ overpressurization. Preventing overpressurization prevents or reduces damage to vascular endothelial lining and to organ tissue in general. Viability of the organ may be automatically monitored, preferably by monitoring characteristics of th emedical fluid perfusate. The perfusion process can be automatically controlled using a control program.
    • 器官灌注装置和方法监测,维持和/或恢复器官和保存器官的存储和/或运输的可行性。 其他装置包括器官输送器,器官盒和器官诊断装置。 该方法包括在低温和/或正常体温温度下灌注器官,优选在用于器官运输和/或储存的低温器官冲洗之后。 该方法可以在先前或随后的器官的静态或灌注低温暴露下进行。 通过用正常体温温度下的医用流体(例如含氧交叉血红蛋白基碳酸氢盐医疗液体)灌注器官来恢复高能量核苷酸(例如ATP)水平来恢复器官活力。 在灌注中,器官灌注压力优选地响应于设置在放置在器官中的管道末端中的传感器,通过气动加压的医用液体储存器进行控制,提供灌注压力微调,超压防止和紧急流量截止。 在低体温模式中,器官用液体灌注,优选地是含有抗氧化剂的简单晶体溶液,间歇地或以缓慢的连续流动。 可以从具有低压头的中间容器将药液输送到器官中,以避免器官过压。 防止过度加压防止或减少对血管内皮衬里和器官组织的损害。 可以自动监测器官的生存能力,优选通过监测体液灌注液的特性。 可以使用控制程序自动控制灌注过程。
    • 8. 发明专利
    • Apparatus and method for maintaining and/or restoring viability of organs
    • AU8677701A
    • 2002-04-08
    • AU8677701
    • 2001-08-27
    • ORGAN RECOVERY SYSTEMS INC
    • OWEN DONALD RKRAVITZ DAVID CBRASSIL JOHNBROCKBANK KELVIN G MBURROUGHS ANDREWISAACS DICKONSTEIBEL DENNIS JFRASER RICHARDHARRIS STANLEYSCHEIN DOUGLAS
    • A01N1/02C12M3/00
    • An organ perfusion apparatus and method monitor, sustain and/or restore viability of organs and preserver organs for storage and/or transport. Other apparatus include an organ transporter, an organ cassette and an organ diagnostic device. The method includes perfusing the organ at hypothermic and/or normothermic temperatures, preferably after hypothermic organ flushing for organ transport and/or storage. The method can be practiced with prior or subsequent static or perfusion hypothermic exposure of the organ. Organ viability is restored by restoring high energy nucleotide (e.g., ATP) levels by perfusing the organ with a medical fluid, such as an oxygeneted cross-linked hemoglobin-based bicarbonate medical fluid, at normothermic temperatures. In perfusion, organ perfusion pressure is preferably controlled in response to a sensor disposed in an end of tubuing placed in the organ, by a pneumatically pressurized medical fluid reservoir, providing perfusion pressure fine tuning, overpressurization preventing and emergency flow cut-off. In the hypothermic mode, the organ is perfused with a medical fluid, preferably a simple crystalloid solution containing antioxidants, intermittently or in slow continuous flow. The medical fluid may be fed into the organ from an intermediary tank having a low pressure head to avoid organ overpressurization. Preventing overpressurization prevents or reduces damage to vascular endothelial lining and to organ tissue in general. Viability of the organ may be automatically monitored, preferably by monitoring characteristics of the medical fluid perfusate. The perfusion process can be automatically controlled using a control program.
    • 9. 发明专利
    • APPARATUS AND METHOD FOR MAINTAINING AND/OR RESTORING VIABILITY OF ORGANS
    • CA2420848A1
    • 2002-04-04
    • CA2420848
    • 2001-08-27
    • ORGAN RECOVERY SYSTEMS INC
    • KRAVITZ DAVID CBRASSIL JOHNOWEN DONALD RHARRIS STANLEYBURROUGHS ANDREWSCHEIN DOUGLASBROCKBANK KELVIN G MFRASER RICHARDISAACS DICKONSTEIBEL DENNIS J
    • A01N1/02C12M3/00
    • An organ perfusion apparatus and method monitor, sustain and/or restore vability of organs and preserver organs for storage and/or transport. Other apparatus include an organ transporter, an organ cassette and an organ diagnostic device. The method includes perfusing the organ at hypothermic and/or normothermic temperatures, preferably after hypothermic organ flushin g for organ transport and/or storage. The method can be practiced with prior o r subsequent static or perfusion hypothermic exposure of the organ. Organ viability is restored by restoring high energy nucleotide (e.g., ATP) levels by perfusing the organ with a medical fluid, such as an oxygeneted cross- linked hemoglobin-based bicarbonate medical fluid, at normothermic temperatures. In perfusion, organ perfusion pressure is preferably controlle d in response to a sensor disposed in an end of tubuing placed in the organ, b y a pneumatically pressurized medical fluid reservoir, providing perfusion pressure fine tuning, overpressurization preventing and emergency flow cut- off. In the hypothermic mode, the organ is perfused with a medical fluid, preferably a simple crystalloid solution containing antioxidants, intermittently or in slow continuous flow. The medical fluid may be fed into the organ from an intermediary tank having a low pressure head to avoid orga n overpressurization. Preventing overpressurization prevents or reduces damage to vascular endothelial lining and to organ tissue in general. Viability of the organ may be automatically monitored, preferably by monitoring characteristics of th emedical fluid perfusate. The perfusion process can be automatically controlled using a control program.
    • 10. 发明公开
    • APPARATUS FOR MAINTAINING AND/OR RESTORING VIABILITY OF ORGANS
    • 设备维护和/或恢复器官的活力
    • EP1317175A2
    • 2003-06-11
    • EP01966245
    • 2001-08-27
    • ORGAN RECOVERY SYSTEMS INC
    • OWEN DONALD RKRAVITZ DAVID CBRASSIL JOHNBROCKBANK KELVIN G MBURROUGHS ANDREWISAACS DICKONSTEIBEL DENNIS JFRASER RICHARDHARRIS STANLEYSCHEIN DOUGLAS
    • A01N1/02C12M3/00
    • A01N1/0273A01N1/02A01N1/0247
    • An organ perfusion apparatus and method monitor, sustain and/or restore viability of organs and preserver organs for storage and/or transport. Other apparatus include an organ transporter, an organ cassette and an organ diagnostic device. The method includes perfusing the organ at hypothermic and/or normothermic temperatures, preferably after hypothermic organ flushing for organ transport and/or storage. The method can be practiced with prior or subsequent static or perfusion hypothermic exposure of the organ. Organ viability is restored by restoring high energy nucleotide (e.g., ATP) levels by perfusing the organ with a medical fluid, such as an oxygeneted cross-linked hemoglobin-based bicarbonate medical fluid, at normothermic temperatures. In perfusion, organ perfusion pressure is preferably controlled in response to a sensor disposed in an end of tubuing placed in the organ, by a pneumatically pressurized medical fluid reservoir, providing perfusion pressure fine tuning, overpressurization preventing and emergency flow cut-off. In the hypothermic mode, the organ is perfused with a medical fluid, preferably a simple crystalloid solution containing antioxidants, intermittently or in slow continuous flow. The medical fluid may be fed into the organ from an intermediary tank having a low pressure head to avoid organ overpressurization. Preventing overpressurization prevents or reduces damage to vascular endothelial lining and to organ tissue in general. Viability of the organ may be automatically monitored, preferably by monitoring characteristics of the medical fluid perfusate. The perfusion process can be automatically controlled using a control program.